◆ Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy.
Radiat Oncol J. 2019 Sep;37(3):215-223.

◆ Radiation hardness of cadmium telluride solar cells in proton therapy beam mode.
PLoS One. 2019 Sep 12;14(9):e0221655

◆ Intensity-modulated radiotherapy for stage I glottic cancer: a short-term outcomes compared with three-dimensional conformal radiotherapy.
Radiat Oncol J. 2019 Dec;37(4):271-278.

◆ Evaluation of Prognostic Factors for the Parotid Cancer Treated With Surgery and Postoperative Radiotherapy.
Clin Exp Otorhinolaryngol. 2020 Feb;13(1):69-76.

◆ Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer.
PLoS One. 2021 Mar 12;16(3):e0248461.

◆ PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy.
Radiat Oncol J. 2022 Mar;40(1):20-28.

◆ Clinical Outcome and Risk Factors of Chronic Radiation Proctitis Following Pelvic Radiation Therapy.
Anticancer Res. 2022 Dec;42(12):5951-5959.

◆ Effect of Interstitial Lung Abnormality on Concurrent Chemoradiotherapy-treated Stage III Non-small Cell Lung Cancer Patients.
Anticancer Res. 2023 Apr;43(4):1797-1807.

◆ Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer.
Oncol Lett. 2023 May 3;25(6):263.

◆ Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21-10).
Radiother Oncol. 2023 Dec;189:109936.